Text Size

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry (AVIATOR)

This study is currently recruiting participants.
Verified July 2011 by Deutsches Herzzentrum Muenchen
Sponsor:
Information provided by:
Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT01390675
First received: June 27, 2011
Last updated: July 8, 2011
Last verified: July 2011
History of Changes
  Purpose

In modern cardiac surgery and cardiology Transcatheter Aortic Valve Implantation (TAVI) is an emergent procedure for high-risk patients that are assumed to be otherwise inoperable. The investigators want to evaluate the specific intraoperative anesthesiologic characteristics cardiac anesthesists have to face during these procedures.


Condition
Heart Failure
Excessive Amount of Blood / Fluid Transfusion
Intraoperative Cardiac Arrest During Cardiac Surgery
Critical Incident

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Deutsches Herzzentrum Muenchen:

Estimated Enrollment: 1000
Study Start Date: June 2011
Estimated Study Completion Date: May 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing transcatheter aortic valve implantation (TAVI)

Criteria

Inclusion Criteria:

- Patients undergoing transcatheter aortic valve implantation (TAVI)

Exclusion Criteria:

- Refusal by patient

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01390675

Contacts
Contact: Patrick N Mayr, M.D. +49 89 1218 ext 4611 mayrp@dhm.mhn.de
Contact: Peter Tassani, M.D., Ph.D +49 89 1218 ext 4611 tassani@dhm.mhn.de

Locations
Germany
Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München Recruiting
Munich, Bavaria, Germany, D-80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Investigators
Principal Investigator: Patrick N Mayr, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Peter Tassani, M.D., Ph.D Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Klaus Martin, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Thomas Ried, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
  More Information

No publications provided

Responsible Party: Patrick N Mayr, MD, Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
ClinicalTrials.gov Identifier: NCT01390675     History of Changes
Other Study ID Numbers: GE DHM-AN-OR-2011/04, GE DHM-AN-OR-2011/04
Study First Received: June 27, 2011
Last Updated: July 8, 2011
Health Authority: Germany: Ethics comittee,Technische Universität München

Additional relevant MeSH terms:
Heart Arrest
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013